© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Sydney Jennings
Articles
New Study Shows Men with Diabetes Have Higher Risk of Disease-related Complications than Women
May 17, 2024
Men with diabetes had a greater risk of CVD, lower limb and kidney complications, and diabetic retinopathy compared to women with diabetes.
Vaping, Drinking Before Pregnancy Not Tied to Higher Risk of Miscarriage: Daily Dose
May 17, 2024
Your daily dose of the clinical news you may have missed.
Cardiovascular-Kidney-Metabolic Syndrome in the US: Daily Dose
May 16, 2024
Your daily dose of the clinical news you may have missed.
AstraZeneca’s Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons
May 16, 2024
Sipavibart met both dual primary endpoints in the SUPERNOVA phase 3 trial.
Irregular Menstrual Cycle Associated with Cardiometabolic Conditions in Women Regardless of PCOS Status
May 15, 2024
New research shows that menstrual irregularity is associated with a higher prevalence of cardiometabolic conditions in women, even in the absence of PCOS.
SGLT2i Use and Improved QoL, Functional Capacity in Adults With HF: Daily Dose
May 15, 2024
Your daily dose of the clinical news you may have missed.
May Issue of Patient Care Online Digital Edition is Now Live
May 14, 2024
Find details on a novel web tool found to help patients determine their eligibility for OTC statin use, FDA clearance of the first AI-based algorithm to detect HF during routine exams, and more.
Colorectal Cancer Rates Significantly Rising among Younger Adults and Teens, According to New Research
May 14, 2024
DDW 24. Among patients aged 15 to 19 years, the incidence of CRC rose 333% over a 22-year period, researchers reported.
FDA Approves Novel Noninvasive Multitarget Stool RNA CRC Screening Test: Daily Dose
May 13, 2024
Your daily dose of the clinical news you may have missed.
Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine
May 10, 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.